Clinical global impressions in Alzheimer's clinical trials

International Psychogeriatrics

Volumn 8, Issue 2, 1996, Pages 277-290

  Schneider, Lon S ^a   Olin, Jason T ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACRINE;

ALZHEIMER DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; HUMAN; INTERVIEW; RATING SCALE; RELIABILITY;

AGED; ALZHEIMER DISEASE; CLINICAL TRIALS; GERIATRIC ASSESSMENT; HUMANS; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0030453871     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610296002645     Document Type: Conference Paper

References (7)

1. Berg, L. (1988). Clinical Dementia Rating. Psychopharmacology Bulletin, 24, 637-639.
2. Boothby, H. (1995). Measuring change in dementia: The reliability of clinical global assessments. In R. Levy & R. Howard (Eds.), Developments in dementia and functional disorders in the elderly (pp. 97-102). England: Wrightson Biomedical Publishing.
3. Dahlke, F., Lohaus, A., & Gutzmann, H. (1992). Reliability and clinical concepts underlying global judgments in dementia: Implications for clinical research. Psychopharmacology Bulletin, 28, 425-432.
4. Davis, K. L., Thal, L. J., Gamzu, E. R., Davis, C. S., Woolson, R. F., et al. (1992). A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. New England Journal of Medicine, 327, 1253-1259.
5. Farlow, M., Gracon, S. I., Hershey, L. A., Louis, K. W., Sadowsky, C. H., et al. (1992). A controlled trial of tacrine in Alzheimer's disease. Journal of the American Medical Association, 268, 2523-2529.
6. Guy, W. (Ed.). (1976). ECDEU assessment manual for psychopharmacology, revised (pp. 218-222). Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Alcohol Drug Abuse and Mental Health Administration, NIMH Psychophannacology Research Branch.
7. Kanowski, S., Fischof, P., Hiersemenzel, R., Röhmel, J., & Kern, U. (1988). Wirksamkeitsnachweis von nootropika am beispiel von Nimodipin - ein beitrag zur entwicklung geeigneter klinischer prüfmodelle [Therapeutic efficacy of nootropic drugs - a discussion of clinical phase III studies with nimodipine as a model]. Zeitscrift für Gerontopsychotogie und psychiatrie, 1, 35-44.